Peptoids and Methods for Treating Alzheimer's Disease


Technology / 12-14:    Peptoids and Methods for Treating Alzheimer's Disease

Inventor:                      Shannon Servoss

Status:                        This invention is available for licensing


General Description

New peptoids have been created that prevent the aggregation of the beta amyloids, and may break up existing amyloids. These peptoids are currently being tested and research is on-going. The new peptoids may be developed into drugs which could be administered to Alzheimer’s patients to prevent further damage to their brains, and possibly even to reverse the effects of the disease.


  • Currently there are no known therapies available that prevent the progression of Alzheimer's Disease


  • Therapeutics for protein aggregation diseases, including Alzheimer's Disease.


Alzheimer’s disease is a devastating disease that progressively robs the memory and the mental abilities of the patient. There currently is no cure for Alzheimer’s, or even a treatment to slow the progression of the disease. Alzheimer’s disease affects more than 26.6 million people worldwide and is predicted to affect 1 in 85 people globally by 2050.


For interested parties seeking further information, feel free to contact:


Mark Allen Lanoue

Technology Manager / Tech Ventures

University of Arkansas

(479) 575-7243



Patent Information:
For Information, Contact:
Mark Lanoue
Technology Manager
University of Arkansas
Shannon Servoss
Melissa Moss
© 2020. All Rights Reserved. Powered by Inteum